Definiens, a provider of image analysis for digital pathology and diagnostics, has entered an agreement with Clarient Diagnostic Services, expanding the use of Definiens’ automated image analysis software and solutions in Clarient’s validated clinical applications for immunohistochemistry testing in breast cancer. Definiens’ Cognition Network Technology automatically classifies and quantitates key tissue features as part of Clarient’s Scope IA Platform offering.   “At Cla...